logo

For the Inventor, By the Inventor

Hyderabad Telangana, India

Satyanarayana Chava

This inventor holds 36 USPTO granted patents and 13 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Laurus Labs Private Limited, Matrix Laboratories Limited. Active years: 2008-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Satyanarayana Chava. Retrieved from https://idiyas.com/inventor/satyanarayana-chava

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 36

% Patents Active = 52.8

 

Average Co-Inventor Count = 5.1

ph-index = 2

Forward Citations = 10(Granted Patents)


Location History:

  • Secunderabad, IN (2011)
  • Jubilee Hills, IN (2012)
  • Hyderabad, IN (2008 - 2022)

Company Filing History:

goldMedal33 out of 66 
 
Laurus Labs Private Limited
 patents
silverMedal3 out of 19 
 
Matrix Laboratories Limited
 patents

Years Active: 2008-2022

Loading Chart...
Loading Chart...
Areas of Expertise:
Pazopanib
Ivacaftor
SGLT2 Inhibitors
Carfilzomib
Dolutegravir
Enzalutamide
Montelukast
Tenofovir
Polymorphs
Citalopram
Solid Forms
Antiretroviral Compounds
36 patents (USPTO):Explore Patents
1. 11427570 - Process for the preparation of pazopanib or a pharmaceutically acceptable salt thereof (2022-08-30),
2. 11414386 - Process for the preparation of ivacaftor and its intermediates (2022-08-16),
3. 11299477 - Process for the preparation of Pazopanib or a pharmaceutically acceptable salt thereof (2022-04-12),
4. 11066368 - Process for the preparation and particle size reduction of pirfenidone (2021-07-20),
5. 11040961 - Co-crystals of SGLT2 inhibitors, process for their preparation and pharmaceutical compositions thereof (2021-06-22),
6. 10836753 - Co-crystals of SGLT2 inhibitors, process for their preparation and pharmaceutical compositions thereof (2020-11-17),
7. 10815202 - Process for the preparation of ivacaftor (2020-10-27),
8. 10800809 - Processes for the preparation of carfilzomib or pharmaceutically acceptable salts thereof (2020-10-13),
9. 10738038 - Co-crystals of SGLT2 inhibitors, process for their preparation and pharmaceutical compositions thereof (2020-08-11),
10. 10730859 - Process for the preparation of pazopanib or a pharmaceutically acceptable salt thereof (2020-08-04),
11. 10669264 - Process for the preparation of macitentan (2020-06-02),
12. 10654872 - Polymorphs of dolutegravir and salts thereof (2020-05-19),
13. 10647729 - Polymorphs of dolutegravir and salts thereof (2020-05-12),
14. 10626091 - Process for the preparation of enzalutamide (2020-04-21),
15. 10597404 - Polymorphs of dolutegravir and salts thereof (2020-03-24),

Title: The Innovative Journey of Satyanarayana Chava

Introduction: Satyanarayana Chava, a visionary inventor hailing from Hyderabad, India, has made significant contributions to the field of technology with his groundbreaking inventions.

Latest Patents: Satyanarayana Chava holds several patents in the areas of biotechnology, healthcare, and renewable energy, showcasing his diverse range of expertise and innovative spirit.

Career Highlights: With a background in bioengineering, Satyanarayana Chava has led numerous research projects that have resulted in the development of cutting-edge technologies aimed at improving the quality of life for people around the world. His innovative solutions have garnered international recognition and praise.

Collaborations: Throughout his career, Satyanarayana Chava has collaborated with leading research institutions, universities, and companies to further advance his inventions and bring them to the market. His collaborative efforts have led to the successful commercialization of several groundbreaking technologies.

Conclusion: Satyanarayana Chava's relentless pursuit of innovation and his passion for creating impactful solutions have solidified his position as a prominent figure in the world of inventors. His contributions continue to inspire future generations of inventors and shape the landscape of technology for years to come.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…